Met Life Investment Management, LLC Cytokinetics Inc Transaction History

Met Life Investment Management, LLC

  • $17.1 Billion
  • Q3 2024

A detailed history of Met Life Investment Management, LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Met Life Investment Management, LLC holds 123,308 shares of CYTK stock, worth $5.65 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
123,308
Previous 122,770 0.44%
Holding current value
$5.65 Million
Previous $6.65 Million 2.12%
% of portfolio
0.04%
Previous 0.04%

Shares

49 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$51.22 - $60.16 $27,556 - $32,366
538 Added 0.44%
123,308 $6.51 Million
Q2 2024

Aug 13, 2024
BUY
$47.86 - $75.05 $1.06 Million - $1.67 Million
22,222 Added 22.1%
122,770 $6.65 Million
Q1 2024

May 14, 2024
BUY
$63.75 - $108.06 $6.41 Million - $10.9 Million
100,548 New
100,548 $7.05 Million
Q3 2023

May 09, 2024
BUY
$29.46 - $36.61 $180,030 - $223,723
6,111 Added 14.22%
49,088 $1.45 Million
Q2 2023

Apr 29, 2024
BUY
$32.62 - $40.75 $1.6 Million - $2 Million
49,088 New
49,088 $1.6 Million
Q2 2023

Aug 10, 2023
BUY
$32.62 - $40.75 $199,340 - $249,023
6,111 Added 14.22%
49,088 $1.6 Million
Q1 2023

May 09, 2024
BUY
$33.36 - $45.71 $1.43 Million - $1.96 Million
42,977 New
42,977 $1.51 Billion
Q3 2022

May 10, 2024
BUY
$38.54 - $54.52 $12,833 - $18,155
333 Added 0.78%
42,977 $2.08 Million
Q3 2022

Mar 22, 2023
BUY
$38.54 - $54.52 $12,833 - $18,155
333 Added 0.78%
42,977 $2.08 Million
Q3 2022

Nov 14, 2022
BUY
$38.54 - $54.52 $12,833 - $18,155
333 Added 0.78%
42,977 $2.08 Million
Q2 2022

May 10, 2024
BUY
$33.93 - $48.92 $1,764 - $2,543
52 Added 0.12%
42,644 $1.68 Million
Q2 2022

Jun 20, 2023
SELL
$33.93 - $48.92 $11,298 - $16,290
-333 Reduced 0.77%
42,644 $1.68 Million
Q2 2022

Mar 22, 2023
BUY
$33.93 - $48.92 $1,764 - $2,543
52 Added 0.12%
42,644 $1.68 Million
Q2 2022

Aug 11, 2022
BUY
$33.93 - $48.92 $1,764 - $2,543
52 Added 0.12%
42,644 $1.68 Million
Q1 2022

May 10, 2024
BUY
$29.74 - $46.0 $1.27 Million - $1.96 Million
42,592 New
42,592 $1.57 Million
Q1 2022

Jun 20, 2023
SELL
$29.74 - $46.0 $11,449 - $17,710
-385 Reduced 0.9%
42,592 $1.57 Million
Q1 2022

Mar 22, 2023
BUY
$29.74 - $46.0 $409,341 - $633,144
13,764 Added 47.75%
42,592 $1.57 Million
Q1 2022

May 12, 2022
BUY
$29.74 - $46.0 $409,341 - $633,144
13,764 Added 47.75%
42,592 $1.57 Million
Q4 2021

Jun 21, 2023
SELL
$34.35 - $46.38 $486,018 - $656,230
-14,149 Reduced 32.92%
28,828 $1.31 Million
Q3 2021

May 17, 2024
BUY
$18.54 - $35.74 $62,127 - $119,764
3,351 Added 13.15%
28,828 $1.03 Million
Q3 2021

Jun 21, 2023
SELL
$18.54 - $35.74 $262,322 - $505,685
-14,149 Reduced 32.92%
28,828 $1.03 Million
Q3 2021

Mar 22, 2023
BUY
$18.54 - $35.74 $62,127 - $119,764
3,351 Added 13.15%
28,828 $1.03 Million
Q3 2021

Nov 15, 2021
BUY
$18.54 - $35.74 $62,127 - $119,764
3,351 Added 13.15%
28,828 $1.03 Million
Q2 2021

Jun 21, 2023
SELL
$19.79 - $26.99 $346,325 - $472,325
-17,500 Reduced 40.72%
25,477 $504,000
Q1 2021

May 17, 2024
SELL
$18.57 - $25.68 $1.39 Million - $1.93 Million
-75,071 Reduced 74.66%
25,477 $592,000
Q1 2021

Jun 26, 2023
SELL
$18.57 - $25.68 $324,975 - $449,400
-17,500 Reduced 40.72%
25,477 $593 Million
Q1 2021

Mar 22, 2023
SELL
$18.57 - $25.68 $55,301 - $76,475
-2,978 Reduced 10.47%
25,477 $592,000
Q1 2021

May 14, 2021
SELL
$18.57 - $25.68 $55,301 - $76,475
-2,978 Reduced 10.47%
25,477 $593,000
Q4 2020

Jun 22, 2023
SELL
$15.26 - $28.61 $221,605 - $415,474
-14,522 Reduced 33.79%
28,455 $591,000
Q3 2020

May 24, 2024
BUY
$20.58 - $28.96 $43,362 - $61,018
2,107 Added 8.0%
28,455 $616 Million
Q3 2020

Jun 26, 2023
SELL
$20.58 - $28.96 $298,862 - $420,557
-14,522 Reduced 33.79%
28,455 $616,000
Q3 2020

Mar 22, 2023
BUY
$20.58 - $28.96 $43,362 - $61,018
2,107 Added 8.0%
28,455 $616,000
Q3 2020

Nov 13, 2020
BUY
$20.58 - $28.96 $43,362 - $61,018
2,107 Added 8.0%
28,455 $616,000
Q2 2020

May 24, 2024
SELL
$11.15 - $24.64 $827,330 - $1.83 Million
-74,200 Reduced 73.8%
26,348 $621 Million
Q2 2020

Jun 26, 2023
SELL
$11.15 - $24.64 $185,413 - $409,738
-16,629 Reduced 38.69%
26,348 $621,000
Q1 2020

Jul 12, 2023
SELL
$8.75 - $16.3 $145,503 - $271,052
-16,629 Reduced 38.69%
26,348 $310,000
Q4 2019

Jul 12, 2023
SELL
$7.95 - $11.84 $132,200 - $196,887
-16,629 Reduced 38.69%
26,348 $279,000
Q3 2019

Jul 12, 2023
SELL
$10.82 - $14.25 $179,925 - $236,963
-16,629 Reduced 38.69%
26,348 $299,000
Q3 2019

Mar 22, 2023
BUY
$10.82 - $14.25 $82,578 - $108,756
7,632 Added 40.78%
26,348 $299,000
Q3 2019

Nov 14, 2019
BUY
$10.82 - $14.25 $82,578 - $108,756
7,632 Added 40.78%
26,348 $300,000
Q2 2019

Jul 12, 2023
SELL
$7.95 - $11.25 $132,200 - $187,076
-16,629 Reduced 38.69%
26,348 $296,000
Q1 2019

Jul 13, 2023
SELL
$5.95 - $10.19 $144,352 - $247,219
-24,261 Reduced 56.45%
18,716 $151,000
Q4 2018

Jul 13, 2023
SELL
$5.91 - $9.29 $143,382 - $225,384
-24,261 Reduced 56.45%
18,716 $118,000
Q4 2018

Mar 22, 2023
SELL
$5.91 - $9.29 $64,046 - $100,675
-10,837 Reduced 36.67%
18,716 $118,000
Q4 2018

Feb 14, 2019
SELL
$5.91 - $9.29 $64,046 - $100,675
-10,837 Reduced 36.67%
18,716 $118,000
Q3 2018

Jul 13, 2023
SELL
$6.4 - $9.85 $155,270 - $238,970
-24,261 Reduced 56.45%
18,716 $184,000
Q3 2018

Mar 22, 2023
SELL
$6.4 - $9.85 $85,913 - $132,226
-13,424 Reduced 31.24%
29,553 $291,000
Q3 2018

Nov 14, 2018
BUY
$6.4 - $9.85 $69,356 - $106,744
10,837 Added 57.9%
29,553 $291,000
Q4 2017

Feb 15, 2018
BUY
$7.25 - $15.65 $135,691 - $292,905
18,716
18,716 $153,000

Others Institutions Holding CYTK

# of Institutions
407
Shares Held
125M
Call Options Held
4.6M
Put Options Held
2.43M
View Full List

About CYTOKINETICS INC

CYTK Quotes by TradingView
  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.31B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email